The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I don't get it, either. As for potential: I bought this for just under £2, after it has slid from a far higher price owing to "losing a big customer".In the company's last report they said they were working on getting more customers and closer to securing deals. The price has continued to fall since then. Very, very annoying.
am i missing something with this stock? financials look good but SP has bombed from £5+ to £1.14? surely this is has potential to hit £1.50+
Anyone have any news on Alfa these days?
Sadly, this now has become a share for day trading within a narrow trading range pending a significant trading update from the company, when some confidence may be restored. From my perspective, it has become a long-term hold. I see no point in averaging down, even at the current low price, as it may trade within this range, or lower, for a considerable time.
This must have occurred today, as I monitored the Share Price on the FTSE-250 index yesterday. I was reasonably confident about this company until the last trading update. Now I am less certain as the share price has received a significant hammering since then. The final nail came from Berenberg; significantly their similar valuation had a similar effect on the Spire Healthcare share price. I see no recourse but to hold indefinitely, in the hope that the apparently incompetent board can effect some contract wins leading to increased revenues here. The CEO’s previous comments were misplaced; however hard he and others within the company are working, they are not delivering at the moment. Let’s hope for an improvement over the next few reporting cycles - it may take a considerable time. Meanwhile, without a dividend to look forward to, there is no recourse but to hold pending an improvement in this company’s performance. GLA
There has been something of a sell off for two shares in my portfolio today - one being Alfa Financial Software Holdings, and the other Spire Healthcare, who issued their half-yer results this morning. Both issued earlier profit warnings, resulting in a severe decline in their share price. In both cases, when the results were formally reported, there was a further decline in the share price to a year low, although the information that was formally communicated was declared prior to the statement being issued. In both cases, the share price was punished on two subsequent occasions, pushing it into oversold territory. A further coincidence lies in the fact that following the initial statement, both companies were given a draconian review and a very low valuation by Berenberg bank. I find all this a little difficult to take on board. It would appear that in both cases some (perhaps frightened) private investors sold off appreciable share holdings in both companies at near year low prices, and at prices well below the NAV for either company.
Just wondering whether it/they were some director sales. As they were locked in for a yr and sold some at £1.80. Hope not. But this share will be above £2 in due course.
Thanks goodflyingduck. I found this definition, which seems to fit the sequence that I observed earlier today - except that my observed sequence were 19 consecutive sells in far too short a time for the trades to be executed manually. Although a large order is mentioned, there is no indication of the sums involved, so that you may be correct. Algorithmic trading is a method of executing a large order (too large to fill all at once) using automated pre-programmed trading instructions accounting for variables such as time, price, and volume to send small slices of the order (child orders) out to the market over time. They were developed so that traders do not need to constantly watch a stock and repeatedly send those slices out manually. Popular "algos" include Percentage of Volume, Pegged, VWAP, TWAP, Implementation Shortfall, Target Close. In the twenty-first century, algorithmic trading has been gaining traction with both retails and institutional traders. Algorithmic trading is not an attempt to make a trading profit. It is simply a way to minimize the cost, market impact and risk in execution of an order. It is widely used by investment banks, pension funds, mutual funds, and hedge funds because these institutional traders need to execute large orders in markets that cannot support all of the size at once.
..... 19 of them consecutively, each 10K pounds worth of shares, between 8:47 and 8:53. What chance does the retail investor have when share prices are controlled electronically in this way?
For once a share price is faring more or less as I had hoped it would. The severe Berenberg valuation (115/Sell) has not had a severe long-term impact on the share price. The same was true in the case of Spire Health. In either case, investors can either bail or sit it out and hope for A positive update which will result in an increase in the share price. Personally, I think that, for both equities, it will take several cycles of results updates before there is a significant improvement. The current prevailing outlook in the UK equity markets does not contribute much optimism to aspiring investors, although there will be good buying opportunities further down the line.
I have no doubt that the recent Berenberg downgrade - Sell / 120 will not help the Alfa share price at the moment. I note with interest that Berenberg put forward a similar valuation i.e. Sell / 120 for Spire Healthcare a month ago when their share price fell substantially mainly due to their failure to maintain revenues from NHS contracts. The German bank s draconian evaluations, if taken seriously, could result in a serious impairment of a company s valuation!
Agreed totally. The last two days saw a market over-reaction to information that was mostly already known. Is the company being punished for taking longer than anticipated to putting appropriate remedial strategies in place? I would have bought more on the drop but had already topped up in anticipation of a rise yesterday, and want to maintain a reasonably balanced portfolio. I am looking forward to a slow return to the 160s, and subsequently a rise to super-200 levels once the CEO and the board are able to deliver on the promises that they made following the previous bigger share price fall.
Hi,
I see that ALFA has been given a 'BUY' rating from Numis ( http://www.lse.co.uk/ShareBrokerTips.asp?shareprice=ALFA&share=alfa_fin ), with a target price of 200.00p. I just wonder what time frame that's in? I do think today was a bit of an over reaction (although the share price made good recovery from the day low!). Hopefully good times ahead.
Good luck all.
Do you think I need to deramp this GFD? Your ignorance is shining like a beacon. Do carry on. The SP performance speaks for itself.
I think they are writ large in the RNS. Weakening dollar,contract delays. Declining SP. No sign of a turnaround. Those enough GFD?
Couldn't resist it sorry :) More seriously I have had this on my watch list. Seems something fundamentally wrong as the SP has never recovered from the large fall. I will wait until the company has ot to grips with its core issues.
the Italian Stock Exchange? I am sure it would be alfa price there. 50% off sure is a bargain!
BOD have had 3 months to come up with some positive developments but essentially they have repeated the bad news and given figures to confirm it. Another big sell off ensues....are they wanting the sp to crash?
Hi,
I've got everything crossed!! Good luck all for tomorrow and beyond.
SP range bound and then all of a sudden the day before results lurches downwards. I am hoping that this is a good sign.
buy now buy now buy now......GL
goodflyingduck. I too am optimistic about this company’s prospects, but let us wait and see what the market thinks when the forthcoming results are declared. I have bought more stock today. I am already well in profit with previous Alfa investments and will now hold for the foreseeable future, as I believe that this company has good growth potential in the long term. All the best to you and all Alfa investors here.
Hi. Hopefully on or around the time when we get the interim results for the six months ending 30 June on Tuesday 4 September.
Good luck all.
I am sure it will fly.......just a case of waiting till it does.......
Hi goodflyingduck. Many thanks for taking the time to reply.
Good luck all.